・2019/6/12

Investment in Symic Holdings, LLC, a U.S. Clinical Stage Biopharmaceutical Company, Developing Novel Extracellular Matrix Targeting Drugs Including a Disease-Modifying Osteoarthritis Drug

・2018/9/18

Investment in Histocell, S.L., a Spanish Clinical-Stage Biopharmaceutical Company, Developing Cell Therapy Products for the Treatment of Acute Spinal Cord Injury and Acute Respiratory Distress Syndrome

・2018/4/24

Allergan Completes Elastagen Acquisition

・2017/8/25

Investment in Steminent Biotherapeutics Inc., a Pioneer of Regenerative Medicine in Taiwan, Developing a Cell-Based Therapy for the Treatment of Spinocerebellar Ataxia

・2016/10/31

Investment in Promethera Biosciences SA, a Spin-Off from the Université Catholique
de Louvain, Developing Cell-Based therapies for the Treatment of Liver Diseases.

・2016/6/16

Investment in Elastagen Pty Ltd, a Venture Company Spin-out from the University of Sydney, Developing Medical Devices for the Treatment of Skin Conditions and Tissue Repair.

・2015/4/20

Final Closing of Cell Innovation Partners, L.P.
News Release by Reprocell.
News Release by Shinsei Corporate Investment.

・2014/9/29

The Launch of Operation of Cell Innovation Partners, L.P.
News Release by Reprocell.
News Release by Shinsei Corporate Investment.